{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:15:48Z","timestamp":1775002548373,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":31,"publisher":"Springer US","isbn-type":[{"value":"9781071652176","type":"print"},{"value":"9781071652183","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5218-3_14","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:20:15Z","timestamp":1774999215000},"page":"187-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microfluidic Shear-Based Assay for Assessing ADAMTS13 Activity Under Flow"],"prefix":"10.1007","author":[{"given":"Noritaka","family":"Yada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/09537104.2017.1306042","volume":"28","author":"RM Schoeman","year":"2017","unstructured":"Schoeman RM, Lehmann M, Neeves KB (2017) Flow chamber and microfluidic approaches for measuring thrombus formation in genetic bleeding disorders. Platelets 28:463\u2013471","journal-title":"Platelets"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1182\/blood-2002-03-0944","volume":"101","author":"M Sugimoto","year":"2003","unstructured":"Sugimoto M, Matsui H, Mizuno T, Tsuji S, Miyata S, Matsumoto M et al (2003) Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood 101:915\u2013920","journal-title":"Blood"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1055\/a-2253-9359","volume":"124","author":"N Yada","year":"2024","unstructured":"Yada N, Zhang Q, Bignotti A, Ye Z, Zheng XL (2024) ADAMTS13 or caplacizumab reduces the accumulation of neutrophil extracellular traps and thrombus in whole blood of COVID-19 patients under flow. Thromb Haemost 124:725\u2013738","journal-title":"Thromb Haemost"},{"key":"14_CR4","doi-asserted-by":"crossref","unstructured":"Yada N, Zhang Q, Bignotti A, Gralnek SH, Sosnovske D, Hogan KO et al (2024) Targeting neutrophil extracellular trap under flow in patients with immune-mediated thrombotic thrombocytopenic purpura. Blood Adv 8:2536\u20132551","DOI":"10.1182\/bloodadvances.2023011617"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.thromres.2015.05.012","volume":"136","author":"BR Branchford","year":"2015","unstructured":"Branchford BR, Ng CJ, Neeves KB, Di Paola J (2015) Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis. Thromb Res 136:13\u201319","journal-title":"Thromb Res"},{"key":"14_CR6","doi-asserted-by":"crossref","unstructured":"Constantinescu-Bercu A, McCann S, Dragunaite B, Sivera R, Tan Y, Keogh L et al (2025) A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission. J Thromb Haemost 23:3185\u20133197","DOI":"10.1016\/j.jtha.2025.06.027"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"HM Tsai","year":"1998","unstructured":"Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585\u20131594","journal-title":"N Engl J Med"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","volume":"95","author":"XL Zheng","year":"2010","unstructured":"Zheng XL, Wu HM, Shang D, Falls E, Skipwith CG, Cataland SR et al (2010) Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica 95:1555\u20131562","journal-title":"Haematologica"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488\u2013494","journal-title":"Nature"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","volume":"106","author":"M Uemura","year":"2005","unstructured":"Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M et al (2005) Localization of ADAMTS13 to the stellate cells of human liver. Blood 106:922\u2013924","journal-title":"Blood"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/labinvest.3700275","volume":"85","author":"W Zhou","year":"2005","unstructured":"Zhou W, Inada M, Lee TP, Benten D, Lyubsky S, Bouhassira EE et al (2005) ADAMTS13 is expressed in hepatic stellate cells. Lab Investig 85:780\u2013788","journal-title":"Lab Investig"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/j.1538-7836.2006.01959.x","volume":"4","author":"N Turner","year":"2006","unstructured":"Turner N, Nolasco L, Tao Z, Dong JF, Moake J (2006) Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost 4:1396\u20131404","journal-title":"J Thromb Haemost"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","volume":"66","author":"XL Zheng","year":"2015","unstructured":"Zheng XL (2015) ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med 66:211\u2013225","journal-title":"Annu Rev Med"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian apheresis study group. N Engl J Med 325:393\u2013397","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"14_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1538-7836.2011.04341.x","volume":"9","author":"Y Fujimura","year":"2011","unstructured":"Fujimura Y, Matsumoto M, Isonishi A, Yagi H, Kokame K, Soejima K et al (2011) Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan. J Thromb Haemost 9(Suppl 1):283\u2013301","journal-title":"J Thromb Haemost"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1172\/JCI26007","volume":"115","author":"DG Motto","year":"2005","unstructured":"Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC et al (2005) Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 115:2752\u20132761","journal-title":"J Clin Invest"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/mt.2008.223","volume":"17","author":"M Niiya","year":"2009","unstructured":"Niiya M, Endo M, Shang D, Zoltick PW, Muvarak NE, Cao W et al (2009) Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes. Mol Ther 17:34\u201341","journal-title":"Mol Ther"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1182\/blood-2010-02-271957","volume":"116","author":"J Huang","year":"2010","unstructured":"Huang J, Motto DG, Bundle DR, Sadler JE (2010) Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice. Blood 116:3653\u20133659","journal-title":"Blood"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1182\/blood-2005-05-2111","volume":"106","author":"LH Nolasco","year":"2005","unstructured":"Nolasco LH, Turner NA, Bernardo A, Tao Z, Cleary TG, Dong JF et al (2005) Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood 106:4199\u20134209","journal-title":"Blood"},{"issue":"3825\u20133829","key":"14_CR20","first-page":"S3821","volume":"121","author":"SY Jin","year":"2013","unstructured":"Jin SY, Xiao J, Bao J, Zhou S, Wright JF, Zheng XL (2013) AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura. Blood 121(3825\u20133829):S3821\u2013S3823","journal-title":"Blood"},{"key":"14_CR21","doi-asserted-by":"crossref","unstructured":"Feitz WJC, Suntharalingham S, Khan M, Ortiz-Sandoval CG, Palaniyar N, van den Heuvel LP et al (2021) Shiga toxin 2a induces NETosis via NOX-dependent pathway. Biomedicines 9:1807","DOI":"10.3390\/biomedicines9121807"},{"key":"14_CR22","doi-asserted-by":"crossref","unstructured":"Zheng XL, Al-Housni Z, Cataland S, Coppo P, Geldziler B, Germini F et al (2025) focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura. J Thromb Haemost 23:3711\u20133732","DOI":"10.1016\/j.jtha.2025.06.002"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1111\/jth.15010","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A et al (2020) ISTH guidelines for treatment of thrombotic thrombocytopenic purpura. J Thromb Haemost 18:2496\u20132502","journal-title":"J Thromb Haemost"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","volume":"390","author":"M Scully","year":"2024","unstructured":"Scully M, Antun A, Cataland SR, Coppo P, Dossier C, Biebuyck N et al (2024) Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura. N Engl J Med 390:1584\u20131596","journal-title":"N Engl J Med"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/j.1538-7836.2011.04224.x","volume":"9","author":"B Plaimauer","year":"2011","unstructured":"Plaimauer B, Kremer Hovinga JA, Juno C, Wolfsegger MJ, Skalicky S, Schmidt M et al (2011) Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies. J Thromb Haemost 9:936\u2013944","journal-title":"J Thromb Haemost"},{"key":"14_CR26","doi-asserted-by":"crossref","unstructured":"Plaimauer B, Schiviz A, Kaufmann S, H\u00f6llriegl W, Rottensteiner H, Scheiflinger F (2015) Neutralization of inhibitory antibodies and restoration of therapeutic ADAMTS-13 activity levels in inhibitor-treated rats by the use of defined doses of recombinant ADAMTS-13. J Thromb Haemost 13:2053\u20132062","DOI":"10.1111\/jth.13137"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1161\/ATVBAHA.115.306014","volume":"35","author":"C Tersteeg","year":"2015","unstructured":"Tersteeg C, Schiviz A, De Meyer SF, Plaimauer B, Scheiflinger F, Rottensteiner H et al (2015) Potential for recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol 35:2336\u20132342","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1182\/blood-2014-07-587139","volume":"125","author":"B Pickens","year":"2015","unstructured":"Pickens B, Mao Y, Li D, Siegel DL, Poncz M, Cines DB et al (2015) Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models. Blood 125:3326\u20133334","journal-title":"Blood"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1161\/ATVBAHA.118.311407","volume":"38","author":"MS Abdelgawwad","year":"2018","unstructured":"Abdelgawwad MS, Cao W, Zheng L, Kocher NK, Williams LA, Zheng XL (2018) Transfusion of platelets loaded with recombinant ADAMTS13 (a Disintegrin and metalloprotease with thrombospondin type 1 Repeats-13) is efficacious for inhibiting arterial thrombosis associated with thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol 38:2731\u20132743","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1161\/ATVBAHA.111.229609","volume":"31","author":"J Xiao","year":"2011","unstructured":"Xiao J, Jin SY, Xue J, Sorvillo N, Voorberg J, Zheng XL (2011) Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis. Arterioscler Thromb Vasc Biol 31:2261\u20132269","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1182\/blood-2007-04-083329","volume":"110","author":"P Zhang","year":"2007","unstructured":"Zhang P, Pan W, Rux AH, Sachais BS, Zheng XL (2007) The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow. Blood 110:1887\u20131894","journal-title":"Blood"}],"container-title":["Methods in Molecular Biology","ADAMTS Proteases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5218-3_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:20:17Z","timestamp":1774999217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5218-3_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071652176","9781071652183"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5218-3_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}